ABVC BioPharma, Inc. (ECOC) Total liabilities 2018–2025
ABVC BioPharma, Inc. (ECOC) total liabilities at each fiscal year-end, per SEC filings.
$7.8MFY2025 · since FY2018: $11.3M → $7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.8M | +13.9% |
| FY2024 | $6.8M | +4.4% |
| FY2023 | $6.5M | +3.0% |
| FY2022 | $6.3M | +31.4% |
| FY2021 | $4.8M | -46.0% |
| FY2020 | $8.9M | +26.8% |
| FY2019 | $7.1M | -37.5% |
| FY2018 | $11.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ECOC financial trends
ECOC RevenueECOC Net incomeECOC Net marginECOC Gross profitECOC Gross marginECOC Operating incomeECOC Operating marginECOC Operating cash flowECOC Free cash flowECOC Capital expendituresECOC Return on equityECOC Stock buybacksECOC Dividends paidECOC Total assetsECOC Shareholders’ equityECOC overview →